Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Phlebitis after Parenteral Iron Sucrose Administration in Postpartum Women

Julia Ramos, MDPhD, Melissa Rosenstein, MD MS, Andrew Leavitt, MD

Blood (2018) 132 (Supplement 1): 1052.

https://doi.org/10.1182/blood-2018-99-113182

Published: 2018

Journal Articles

Influenza Vaccination Rates during the First Year after Diagnosis of Diffuse Large B Cell Lymphoma

Andres Chang, MD PhD, Jackelyn B. Payne, MPH, BS, BA, Pamela Allen, MD MSc, Jean L. Koff, MD, Rafi Ahmed, PhD, Christopher R Flowers, MD MS, Robert A Bednarczyk, PhD

Blood (2018) 132 (Supplement 1): 4820.

https://doi.org/10.1182/blood-2018-99-117168

Published: 2018

Journal Articles

Soluble P-Selectin and Age Adjusted D-Dimer As Predictive Biomarkers of Venous Thrombosis

Dana E Angelini, MD, Cathy Stabler, R.N., Angela E. Hawley, Kenneth E. Guire, M.S., Daniel Durant Myers, DVM,MPH, Susan Blackburn, R.N., Thomas W. Wakefield, MD, Suman L. Sood, MD

Blood (2014) 124 (21): 2863.

https://doi.org/10.1182/blood.V124.21.2863.2863

Published: 2014

Journal Articles

Palliative Care For Patients With Hematologic Malignancies: A Profile Of Patients With Blood Cancers Referred To The Choice Hospice Network

Thomas W. LeBlanc, MD, MA, Amy P Abernethy, MD, PhD, David J Casarett, MD, MA

Blood (2013) 122 (21): 1678.

https://doi.org/10.1182/blood.V122.21.1678.1678

Published: 2013

Journal Articles

Access to Care, Race and Education Are Key Determinants of Erythropoietin Stimulating Agent (ESA) Use In Myelodysplastic Syndromes (MDS).

Amy J. Davidoff, PhD, M.S., Sheila Weiss Smith, PhD, Maria R Baer, M.D., Xuehua Ke, M.A., Jason M Bierenbaum, M.D., Franklin Hendrick, B.S., Diane L. McNally, BSPharm, M.S., Steven D. Gore, M.D.

Blood (2010) 116 (21): 3815.

https://doi.org/10.1182/blood.V116.21.3815.3815

Published: 2010

Journal Articles

Phase II Study of Thalidomide in Escalating Doses for Follicular (F-NHL) and Small Lymphocytic Lymphoma (Sll): CALGB Study 50002.

David L. Grinblatt, M.D., Jeffrey Johnson, Donna Niedzwicki, Ph.D., David A. Rizzieri, M.D., Nancy Bartlett, M.D., Bruce D. Cheson, M.D.

Blood (2004) 104 (11): 3284.

https://doi.org/10.1182/blood.V104.11.3284.3284

Published: 2004

NARROW

Phlebitis after Parenteral Iron Sucrose Administration in Postpartum Women

Influenza Vaccination Rates during the First Year after Diagnosis of Diffuse Large B Cell Lymphoma

Soluble P-Selectin and Age Adjusted D-Dimer As Predictive Biomarkers of Venous Thrombosis

Palliative Care For Patients With Hematologic Malignancies: A Profile Of Patients With Blood Cancers Referred To The Choice Hospice Network

Access to Care, Race and Education Are Key Determinants of Erythropoietin Stimulating Agent (ESA) Use In Myelodysplastic Syndromes (MDS).

Phase II Study of Thalidomide in Escalating Doses for Follicular (F-NHL) and Small Lymphocytic Lymphoma (Sll): CALGB Study 50002.

Email alerts

ASH Publications

American Society of Hematology

Phlebitis after Parenteral Iron Sucrose Administration in Postpartum Women

Influenza Vaccination Rates during the First Year after Diagnosis of Diffuse Large B Cell Lymphoma

Soluble P-Selectin and Age Adjusted D-Dimer As Predictive Biomarkers of Venous Thrombosis

Palliative Care For Patients With Hematologic Malignancies: A Profile Of Patients With Blood Cancers Referred To The Choice Hospice Network

Access to Care, Race and Education Are Key Determinants of Erythropoietin Stimulating Agent (ESA) Use In Myelodysplastic Syndromes (MDS).

Phase II Study of Thalidomide in Escalating Doses for Follicular (F-NHL) and Small Lymphocytic Lymphoma (Sll): CALGB Study 50002.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only